Sung H. Lee serves as the Principal Financial Officer at Cytokinetics, Inc., a biopharmaceutical company focused on developing groundbreaking muscle activators and inhibitors as potential treatments for debilitating diseases. In his role, Lee is responsible for overseeing the financial operations and strategy of the company, ensuring its fiscal health and supporting its mission to bring innovative therapies to patients in need. His expertise in financial management and strategic planning has been instrumental in guiding Cytokinetics through various stages of growth and development. Prior to joining Cytokinetics, Lee held several senior financial positions at various organizations, where he honed his skills in financial planning, analysis, and corporate strategy. His professional background includes significant experience in the biotechnology and pharmaceutical sectors, making him well-suited to navigate the complex financial landscape of drug development and commercialization. Lee's achievements in his previous roles have earned him a reputation as a forward-thinking leader capable of driving financial performance while maintaining a strong focus on corporate governance and compliance. At Cytokinetics, Lee has played a key role in securing funding for the company's research and development efforts, as well as in managing its financial resources to support ongoing clinical trials and the advancement of its pipeline. His strategic vision and financial acumen have been crucial in positioning Cytokinetics for long-term success and in fostering collaborations with industry partners. Under his leadership, the company continues to make strides in its mission to transform the treatment landscape for patients with serious medical conditions.